PropThink: Stem Cell Divestiture May Benefit Geron Shareholders More than the Company

[ACN Newswire] – By Jake KingGeron Corp (NASDAQ:GERN) may have finally found a buyer for its suspended stem cell program. The company has been searching since November of 2011 when Geron halted the projects to focus on … more

View todays social media effects on GERN

View the latest stocks trending across Twitter. Click to view dashboard